Evaluating the Evidence on Comparative Effectiveness and Value of Management Options for Treatment-Resistant Depression

被引:3
作者
Emond, Sarah K. [1 ]
Ollendorf, Daniel A. [1 ]
Colby, Jennifer A. [1 ]
Reed, Sarah Jane [1 ]
Pearson, Steven D. [1 ]
机构
[1] Inst Clin & Econ Review, Boston, MA 02109 USA
关键词
treatment-resistant depression; repetitive transcranial magnetic stimulation; evidence-based medicine; comparative effectiveness research; VAGUS NERVE-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION;
D O I
10.3810/pgm.2013.11.2707
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Treatment-resistant depression (TRD) is a debilitating patient condition with significant clinical and economic impact. The introduction of anew treatment approach, repetitive transcranial magnetic stimulation (rTMS), created the opportunity for a multi-stakeholder initiative to examine the comparative clinical effectiveness and comparative value of the different approaches to managing patients with TRD. The New England Comparative Effectiveness Public Advisory Council (CEPAC) convened in December 2011 to discuss the evidence on management options for patients with TRD. The Council voted that rTMS was as good or better than usual care and represented a reasonable value compared with usual care. The votes and deliberation of CEPAC led to first-in-the-nation payer coverage policies allowing patients access to this new treatment option. Regional groups that examine and deliberate on the comparative effectiveness evidence for existing and emerging treatments can have a direct influence on medical policy that accelerates access to innovative treatments.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 50 条
  • [31] Neurostimulatory therapeutics in management of treatment-resistant depression with focus on deep brain stimulation
    Dumitriu, Dani
    Collins, Kate
    Alterman, Ron
    Mathew, Sanjay J.
    MOUNT SINAI JOURNAL OF MEDICINE, 2008, 75 (03): : 263 - 275
  • [32] Treatment-resistant depression: Established and emerging therapies
    Mcbroom, Leesa A.
    Timmons, Melissa
    NURSE PRACTITIONER, 2024, 49 (12) : 35 - 40
  • [33] Magnetic seizure therapy for treatment-resistant depression
    Hoy, Kate E.
    Fitzgerald, Paul B.
    EXPERT REVIEW OF MEDICAL DEVICES, 2011, 8 (06) : 723 - 732
  • [34] Deep Brain Stimulation for Treatment-Resistant Depression
    Holtzheimer, Paul E., III
    Mayberg, Helen S.
    AMERICAN JOURNAL OF PSYCHIATRY, 2010, 167 (12) : 1437 - 1444
  • [35] A Southeast Asia Consensus on the Definition and Management of Treatment-Resistant Depression
    Tor, Phern Chern
    Amir, Nurmiati
    Fam, Johnson
    Ho, Roger
    Ittasakul, Pichai
    Maramis, Margarita
    Ponio, Benita
    Purnama, Dharmawan Ardi
    Rattanasumawong, Wanida
    Rondain, Elizabeth
    Bin Sulaiman, Ahmad Hatim
    Wiroteurairuang, Kannokarn
    Chee, Kok Yoon
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 2747 - 2757
  • [36] TREATMENT-RESISTANT DEPRESSION IN ADOLESCENTS: REVIEW AND UPDATES ON CLINICAL MANAGEMENT
    Maalouf, Fadi T.
    Atwi, Mia
    Brent, David A.
    DEPRESSION AND ANXIETY, 2011, 28 (11) : 946 - 954
  • [37] The Integrative Management of Treatment-Resistant Depression: A Comprehensive Review and Perspectives
    Carvalho, Andre F.
    Berk, Michael
    Hyphantis, Thomas N.
    McIntyre, Roger S.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2014, 83 (02) : 70 - 88
  • [38] Efficacy of repetitive transcranial magnetic stimulation in treatment-resistant depression: the evidence thus far
    Somani, Aditya
    Kar, Sujita Kumar
    GENERAL PSYCHIATRY, 2019, 32 (04)
  • [39] Treatment-resistant depression. From classification to new therapies.
    Paganin, Walter
    Signorini, Sabrina
    Leccese, Vincenzo
    Sciarretta, Antonio
    RIVISTA DI PSICHIATRIA, 2022, 57 (06) : 258 - 272
  • [40] Evidence-based options for treatment-resistant adult bipolar disorder patients
    Poon, Shi Hui
    Sim, Kang
    Sum, Min Yi
    Kuswanto, Carissa Nadia
    Baldessarini, Ross J.
    BIPOLAR DISORDERS, 2012, 14 (06) : 573 - 584